Linda R. Peterson

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Joshua D. Mitchell · 2 shared papers, 2024–2025 · strength 0.73
   • Paper ASO Author Reflections: Plasma Ceramide Levels Aid in Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-025-17274-0↗
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
2. William G. Hawkins · 3 shared papers, 2023–2024 · strength 0.52
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
   • Paper Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid t… DOI 10.1016/j.acra.2023.11.012↗
   • Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2↗
3. Joseph E. Ippolito · 3 shared papers, 2023–2024 · strength 0.52
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
   • Paper Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid t… DOI 10.1016/j.acra.2023.11.012↗
   • Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2↗
4. Ryan C Fields · 2 shared papers, 2024 · strength 0.37
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
   • Paper Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid t… DOI 10.1016/j.acra.2023.11.012↗
5. Timothy M. Nywening · 1 shared paper, 2024 · strength 0.19
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
6. Adetunji T. Toriola · 1 shared paper, 2024 · strength 0.19
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
7. Usman Younis Panni · 1 shared paper, 2024 · strength 0.19
   • Paper Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-16245-1↗
8. David H. Ballard · 1 shared paper, 2024 · strength 0.18
   • Paper Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid t… DOI 10.1016/j.acra.2023.11.012↗
9. Daniel R. Ludwig · 1 shared paper, 2024 · strength 0.18
   • Paper Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid t… DOI 10.1016/j.acra.2023.11.012↗
10. Lauren K. Park · 1 shared paper, 2023 · strength 0.14
    • Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2↗
11. Kian‐Huat Lim · 1 shared paper, 2023 · strength 0.14
    • Paper Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combi… DOI 10.1186/s40170-023-00306-2↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.